Ping Xiaorui, Liang Xiaoyun, Xing Wenlu, Wang Saiqi, Gong Fengcongzhe, Cheng Yaqi, Duan Songqi, Lv Xueqi, Li Xueying, Zhang Tianli, Chen Chunxiao, Zhang Yuxin, Yuan Chengzhu, Liu Shangyu, Liu Gang, Sun Baofa
State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin 300071, China.
Department of Cardiology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, China.
Theranostics. 2025 Mar 29;15(10):4785-4807. doi: 10.7150/thno.104179. eCollection 2025.
: Atherosclerosis is a chronic inflammatory disease that is the major cause of mortality worldwide. Although several studies have assessed the function of mA (N-methyladenosine) modification in atherosclerosis, its regulatory mechanism at the single-cell level remains unclear. This study provides a comprehensive single-cell atlas of mA modification regulating cell-type-specific functions in atherosclerosis. : We analyzed single-cell sequencing data derived from atherosclerosis patients to elucidate the influence of mA modification on diverse cell types. We demonstrated the potential regulatory functions of mA regulators across various cell types and key transcription factors involved. Furthermore, we discovered mA regulators mediated intercellular communication in important biological processes. experiments were conducted to further investigate the effects of ALKBH5, WTAP and METTL3 on atherosclerosis. : upregulated in endothelial cells induced cell proliferation and migration involved in sprouting angiogenesis. In smooth muscle cells, upregulation of enhanced proliferation, migration and phenotypic transformation. Upregulation of and promoted macrophage activation and differentiation. Furthermore, we identified abnormally activated transcription factors could regulate mA regulators in a cell-type-specific manner. Moreover, we revealed that mA regulators were implicated in dysregulated intercellular communication in atherosclerosis. And a series of experimental validations supported the conclusion that mA regulators exert cell-type-specific regulatory functions. : Our study provided evidence for the roles of ALKBH5, WTAP and METTL3 in orchestrating atherosclerotic cell-type-specific functions, representing promising targets for precision medicine.
动脉粥样硬化是一种慢性炎症性疾病,是全球范围内主要的死亡原因。尽管多项研究评估了m⁶A(N-甲基腺苷)修饰在动脉粥样硬化中的作用,但其在单细胞水平的调控机制仍不清楚。本研究提供了一个全面的m⁶A修饰单细胞图谱,其可调节动脉粥样硬化中细胞类型特异性功能。
我们分析了来自动脉粥样硬化患者的单细胞测序数据,以阐明m⁶A修饰对不同细胞类型的影响。我们展示了m⁶A调节剂在各种细胞类型和相关关键转录因子中的潜在调控功能。此外,我们发现m⁶A调节剂在重要生物学过程中介导细胞间通讯。进行了实验以进一步研究ALKBH5、WTAP和METTL3对动脉粥样硬化的影响。
在内皮细胞中上调可诱导参与发芽血管生成的细胞增殖和迁移。在平滑肌细胞中,上调可增强增殖、迁移和表型转化。上调和可促进巨噬细胞活化和分化。此外,我们鉴定出异常激活的转录因子可在细胞类型特异性的方式下调节m⁶A调节剂。而且,我们揭示m⁶A调节剂与动脉粥样硬化中失调的细胞间通讯有关。一系列实验验证支持了m⁶A调节剂发挥细胞类型特异性调控功能这一结论。
我们的研究为ALKBH5、WTAP和METTL3在协调动脉粥样硬化细胞类型特异性功能中的作用提供了证据,代表了精准医学的有前景的靶点。